2014
DOI: 10.4244/eijv10sua16
|View full text |Cite
|
Sign up to set email alerts
|

Medtronic transcatheter mitral valve replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Transapical transcatheter valve implantation for mitral valve prosthesis failure (TAVI-in-ring) has been carried out successfully71 as has implantation for the management of native mitral stenosis 72. Prototype devices for percutaneous mitral valve replacement are also under investigation with encouraging initial experiences demonstrating good short-term efficacy 73 74…”
Section: Expanding Indicationsmentioning
confidence: 99%
“…Transapical transcatheter valve implantation for mitral valve prosthesis failure (TAVI-in-ring) has been carried out successfully71 as has implantation for the management of native mitral stenosis 72. Prototype devices for percutaneous mitral valve replacement are also under investigation with encouraging initial experiences demonstrating good short-term efficacy 73 74…”
Section: Expanding Indicationsmentioning
confidence: 99%
“…MitraClip (Abbott Vascular, Santa Clara, CA, USA) implantation is currently the most commonly utilised transcatheter therapy for severe MR. Clinical trials show that, although MitraClip implantation is relatively safe, an effective and durable outcome is frequently not achieved [15][16][17][18] . Transcatheter mitral valve implantation (TMVI) is a novel approach that may, theoretically, enable a more effective reduction in MR severity [19][20][21][22] . A significant concern is that a transcatheter valve cannot be implanted after a MitraClip has been deployed and released.…”
Section: Introductionmentioning
confidence: 99%